News
Kewaunee's Net Sales Increase Y/Y, Earnings Decline in Q2
Shares of Kewaunee Scientific Corporation KEQU have declined 1.3% since reporting results for the second quarter of fiscal 2026. This compares with the S&P 500 index’s 0.7% return over the same time
Oil-Dri Q1 Earnings Decline Y/Y Amid Tough Comparison Pressures
Shares of Oil-Dri Corporation of America ODC have underperformed the broader market following the release of its first-quarter fiscal 2026 results. Shares of Oil-Dri have declined 6.7% since
BALL to Boost Presence With Stake in Benepack's European Can Business
Ball Corporation BALL announced that it inked a definitive agreement to buy an 80% stake in Benepack's European beverage can manufacturing businesses. The move optimizes Ball Corp’s European
AI-Driven Personalization Fuels SFIX's Rising AOV & RPAC in Early FY26
Stitch Fix, Inc. SFIX entered fiscal 2026 with accelerating Average Order Value (AOV) growth, reinforcing the strength of its transformation strategy. In the fiscal first quarter, AOV increased 9.6%
lululemon Surpasses Revenues & Earnings in Q3, Lifts FY25 View
lululemon athletica inc. LULU reported third-quarter fiscal 2025 results, wherein revenues and earnings per share (EPS) beat the Zacks Consensus Estimate. The company’s top line improved year over
3 Gas Distribution Stocks to Buy From a Challenging Industry
Is Interactive Brokers a Buy as It Scales Global Market Access?
Interactive Brokers Group, Inc.’s IBKR greatest strength in the brokerage space stems from its deep, multi-asset global market access, which remains unmatched by most retail and even many
DIS' OpenAI Partnership Boosts AI Footprint: Time to Hold the Stock?
Disney's DIS landmark $1 billion investment in OpenAI positions the entertainment giant at the forefront of generative AI adoption, yet persistent headwinds in linear television and streaming
Broadcom Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Fall
Broadcom AVGO reported fourth-quarter fiscal 2025 non-GAAP earnings of $1.95 per share, beating the Zacks Consensus Estimate by 4.3% and jumping 37.3% year over year.Revenues rallied 28.2% year over
SkyWest's EPS Estimates Northbound: Should Investors Buy the Stock?
SkyWest, Inc. (SKYW) has been benefiting from flying contract rate increases, fleet modernization techniques and consistent shareholder-friendly initiatives. The positive sentiment surrounding SKYW
Should Investors Hold Old Dominion Stock Despite Its Higher Valuation?
Old Dominion Freight Line, Inc. (ODFL) looks highly unattractive from a valuation standpoint. Considering the forward 12-month price-to-sales ratio (P/S-F12M), ODFL has a forward 12-month P/S-F12M
Qualcomm Just Got Called an AI Loser—So Why Is It Rallying?
Shares of Qualcomm Inc. (NASDAQ: QCOM) were trading up more than 2% on the morning of Wednesday, Dec. 10, marking their longest stretch of gains in months and putting the stock up 12% in just a
NVO Down 42% Year to Date: Is This an Indication to Sell the Stock?
Novo Nordisk NVO has stumbled through 2025, with its shares down 41.5% year to date despite finally resolving U.S. supply constraints for its semaglutide-based GLP-1 blockbusters — Ozempic for type
Can Opdivo's Label Expansions Help Bristol Myers Sustain Its Momentum?
Bristol Myers BMY has a broad oncology portfolio, which includes blockbuster immuno-oncology drugs, Opdivo, Opdivo Qvantig and Yervoy, among others.
Among these, Opdivo (nivolumab) is the top
Pre-markets Mixed Ahead of Consequential Week of Data
Friday, December 12, 2025Pre-market futures are averaging out to be flat at this hour, although we’re seeing a wider band of trading. The blue-chip Dow and the small-cap Russell 2000 — up +110
Can Tesla's New Discounts on Model Y Help Boost Q4 Deliveries?
Electric Vehicle (EV) giant Tesla TSLA has introduced an all-out discount strategy to boost fourth-quarter sales numbers for Model Y. As the company is in the final leg of the year, it is offering a
Synopsys Q4 Earnings Surpass Estimates, Revenues Rise Y/Y
Synopsys SNPS reported non-GAAP earnings of $2.90 per share for the fourth quarter of fiscal 2025, which beat the Zacks Consensus Estimate by 3.94%. The bottom line decreased 14.7% on a
Daktronics' Q2 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Fall
Daktronics DAKT shares fell 1.87% to close at $20.51 on Thursday following second-quarter fiscal 2026 results reported on Dec. 10. Earnings of 35 cents per share surpassed the Zacks Consensus
Kymera's Eczema Drug Gets Fast Track Designation in the United States
Kymera Therapeutics, Inc. KYMR recently announced that the FDA granted Fast Track designation to pipeline candidate KT-621 for the treatment of moderate to severe atopic dermatitis (AD), the most
ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform
AtriCure ATRC recently took a major step forward in surgical ablation innovation with the first patients successfully treated using its new dual-energy platform. The system uniquely pairs Pulsed
Can Verizon's Empower Field Network Infrastructure Upgrade Aid Shares?
Verizon Communications Inc. (VZ) has introduced a new Wi-Fi 6E network at Empower Field at Mile High, home of the Denver Broncos. With Verizon’s upgraded Wi-Fi 6E and LAN, fans can now enjoy a
Clorox's Brand Investments Are Up: Will They Translate to Growth?
The Clorox Company’s CLX brand investments are increasing due to heightened demand creation strategies, including higher trade spending and advertising to support innovations planned for the second


